DIA423.48+2.93 0.70%
SPX5,916.93+24.35 0.41%
IXIC19,112.32-34.49 -0.18%

GE HealthCare (GEHC) Reports Q1: Everything You Need To Know Ahead Of Earnings

Barchart·04/29/2025 02:46:10
Listen to the news

GEHC Cover Image

Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) will be reporting earnings tomorrow before market hours. Here’s what to expect.

GE HealthCare met analysts’ revenue expectations last quarter, reporting revenues of $5.32 billion, up 2.2% year on year. It was a satisfactory quarter for the company, with a solid beat of analysts’ EPS estimates.

Is GE HealthCare a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting GE HealthCare’s revenue to be flat year on year at $4.66 billion, improving from the 1.2% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.91 per share.

GE HealthCare Total Revenue

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. GE HealthCare has missed Wall Street’s revenue estimates six times over the last two years.

Looking at GE HealthCare’s peers in the healthcare equipment and supplies segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Penumbra delivered year-on-year revenue growth of 16.3%, beating analysts’ expectations by 2.7%, and Boston Scientific reported revenues up 20.9%, topping estimates by 2%. Penumbra traded up 7.2% following the results while Boston Scientific was also up 6.5%.

Read our full analysis of Penumbra’s results here and Boston Scientific’s results here.

Questions about potential tariffs and corporate tax changes have caused much volatility in 2025. While some of the healthcare equipment and supplies stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 5.2% on average over the last month. GE HealthCare is down 15.6% during the same time and is heading into earnings with an average analyst price target of $97.01 (compared to the current share price of $68.14).

Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.